Professor Robin Choudhury

Professor Choudhury has established the Cardiovascular PIT-STOP®, which provides comprehensive, integrated cardiovascular risk assessment. He has particular expertise in cholesterol management, including lifestyle, diet, and drug treatments.

PIT – Primary Intensive Treatment: For individuals concerned about assessing their cardiovascular risk and minimising their lifelong chance of heart disease.

STOP – Secondary Treatment Optimisation Programme: For patients who have already had a heart attack, stent, or bypass operation and wish to minimise the risk of recurrence or progression.

Professor Choudhury also assesses and manages a range of general cardiology conditions. Some of the conditions he treats and condition he treats are given below:

• Chest pain
• Shortness of breath
• Palpitation
• High blood pressure
• High Cholesterol
• Coronary disease
• Angina
• Valve disease 
• Diabetes
• Heart attack

Qualifications

• BA – Oxford
• BM, BCh – Oxford
• DM – Oxford
• FRCP (London)
• FESC

Honours:

• Fellowship of the European Society of Cardiology
• Fellowship of the American College of Cardiologists

Awards and named lectures:

• Jacob Marschak Colloquium (University of California, Los Angeles, UCLA)
• Distinguished Visiting Professor (University of Toronto)
• Wellcome Trust Senior Research Fellowship in Clinical Science
• John French Lecture (British Atherosclerosis Society)
• Herbert Kayden Lecture (New York University)
• Wellcome Trust Prize International Fellowship
• Graham-Dixon Prize in Clinical Cardiology (Imperial College)

Professor Choudhury is a Professor of Cardiovascular Medicine at the University of Oxford and Research Fellow in Biomedical Sciences at Balliol. He is an Affiliated Researcher at the Institute of Regenerative Medicine. He is co-PI of of the NovoNordisk Foundation supported Metabolite-related inflammation and disease (MeRIAD) consortium; Joint clinical lead in the MRC-BHF Centre of Research Excellence in Advanced Cardiac Therapies (REACT) and UK Chief Investigator for the ZEUS clinical trial of Ziltivekimab.

You can read more about Professor Choudhury’s research here.

You can read more about Professor Choudhury in the media below:

• The Telegraph – Miranda Levy Should I take statins? I’m weighing up the pros and cons before I commit https://www.telegraph.co.uk/health-fitness/conditions/heart-health/statins-pros-cons/
• CNN Statins and Cardiovascular Risk https://edition.cnn.com/2016/09/08/health/study-explores-pros-and-cons-of-statins/index.html 
• The Spectator: Health Heart disease – genes or lifestyle? https://health.spectator.co.uk/heart-disease-genes-lifestyle-best-answer-yet/ 
• The Spectator: Health To make an informed choice about statins, here is what you should know https://health.spectator.co.uk/statins-controversies-hide-the-true-story-that-evidence-for-their-use-just-gets-stronger/ 
• Mail on Sunday Six foods that will cut your cholesterol http://www.dailymail.co.uk/health/article-2272401/The-foods-cut-cholesterol-just-months--dont-cheese-chocolate-breakfast-egg.html 
• Evening Standard High blood sugar levels reprogramme stem cells, study suggests https://www.standard.co.uk/news/uk/university-of-oxford-british-heart-foundation-david-davies-b945638.html 
• Daily Mail The 100-year-old anti-inflammatory gout drug that can stop heart attacks https://www.dailymail.co.uk/health/article-10306145/The-100-year-old-gout-drug-stop-heart-attacks.html 
• Financial Times Thinking 3D: Leonardo to the present at Oxford’s Bodleian Libraries https://www.ft.com/content/a1c9f252-4a6a-11e9-bde6-79eaea5acb64 
• BBC Radio 5 Live – Rachel Burden Polypill on the NHS https://www.bbc.co.uk/sounds/play/m0028lt1 
• Nature Inflammation in heart disease: do researchers know enough? https://www.nature.com/articles/d41586-021-01453-6 
• Scientific American Inflammation in Heart Disease: Do Researchers Know Enough? https://www.scientificamerican.com/article/inflammation-in-heart-disease-do-researchers-know-enough/